Jeffrey L. Havens

508 total citations
10 papers, 436 citations indexed

About

Jeffrey L. Havens is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Jeffrey L. Havens has authored 10 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Jeffrey L. Havens's work include HIV/AIDS drug development and treatment (3 papers), Analytical Chemistry and Chromatography (2 papers) and Chemical Synthesis and Reactions (2 papers). Jeffrey L. Havens is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), Analytical Chemistry and Chromatography (2 papers) and Chemical Synthesis and Reactions (2 papers). Jeffrey L. Havens collaborates with scholars based in United States and Japan. Jeffrey L. Havens's co-authors include William G. Salmond, Rajappa Vaidyanathan, P. A. MEULMAN, Ronald W. Sarver, Bruce A. Pearlman, Mark A. Lyster, Michael Hawley, Michael S. Bergren, Kathleen A. Farley and Russell H. Robins and has published in prestigious journals such as The Journal of Organic Chemistry, International Journal of Pharmaceutics and Organic Letters.

In The Last Decade

Jeffrey L. Havens

10 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey L. Havens United States 7 308 123 46 46 42 10 436
Gregory Hahn United States 7 465 1.5× 128 1.0× 34 0.7× 23 0.5× 44 1.0× 7 537
Naresh K. Chadha United States 11 420 1.4× 172 1.4× 41 0.9× 24 0.5× 25 0.6× 14 546
David M. Hollinshead United Kingdom 13 320 1.0× 119 1.0× 42 0.9× 26 0.6× 50 1.2× 17 450
D. H. R. Barton United States 14 339 1.1× 224 1.8× 46 1.0× 31 0.7× 48 1.1× 24 615
Ajoy K. Banerjee Venezuela 10 395 1.3× 179 1.5× 47 1.0× 27 0.6× 36 0.9× 105 567
Heinrich Becker United States 12 592 1.9× 188 1.5× 65 1.4× 33 0.7× 54 1.3× 17 724
Yasunori Kitano Japan 13 460 1.5× 180 1.5× 43 0.9× 31 0.7× 54 1.3× 26 598
Kevin E. Henegar United States 12 267 0.9× 137 1.1× 36 0.8× 16 0.3× 36 0.9× 20 372
Thomas V. Lee United Kingdom 13 393 1.3× 125 1.0× 34 0.7× 32 0.7× 36 0.9× 46 486
Rolf Henning Germany 7 595 1.9× 115 0.9× 47 1.0× 22 0.5× 42 1.0× 12 646

Countries citing papers authored by Jeffrey L. Havens

Since Specialization
Citations

This map shows the geographic impact of Jeffrey L. Havens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Havens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Havens more than expected).

Fields of papers citing papers by Jeffrey L. Havens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey L. Havens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Havens. The network helps show where Jeffrey L. Havens may publish in the future.

Co-authorship network of co-authors of Jeffrey L. Havens

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey L. Havens. A scholar is included among the top collaborators of Jeffrey L. Havens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey L. Havens. Jeffrey L. Havens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wuts, Peter G. M., et al.. (2009). A Scalable Synthesis of the INOS Inhibitor PHA-399733. Organic Process Research & Development. 13(2). 331–335. 2 indexed citations
2.
3.
Havens, Jeffrey L., et al.. (2003). Early Amidation Approach to 3-[(4-Amido)pyrrol-2-yl]-2-indolinones. The Journal of Organic Chemistry. 68(16). 6447–6450. 82 indexed citations
4.
Sarver, Ronald W., et al.. (1998). Factor analysis of infrared spectra for solid-state forms of delavirdine mesylate. International Journal of Pharmaceutics. 167(1-2). 105–120. 20 indexed citations
5.
Farley, Kathleen A., Gregory S. Walker, Russell H. Robins, et al.. (1996). Spectroscopic studies of delavirdine mesylate (U‐90,152T) a bis(heteroaryl)piperazine (BHAP) HIV reverse transcriptase inhibitor. Journal of Heterocyclic Chemistry. 33(2). 493–496. 2 indexed citations
6.
Bergren, Michael S., P. A. MEULMAN, Ronald W. Sarver, et al.. (1996). Solid Phases of Delavirdine Mesylate. Journal of Pharmaceutical Sciences. 85(8). 834–841. 9 indexed citations
7.
Salmond, William G., et al.. (1978). ChemInform Abstract: ALLYLIC OXIDATION WITH 3,5‐DIMETHYLPYRAZOLE. CHROMIUM TRIOXIDE COMPLEX STEROIDAL Δ5‐7‐KETONES. Chemischer Informationsdienst. 9(40). 24 indexed citations
8.
Salmond, William G., et al.. (1978). Allylic oxidation with 3,5-dimethylpyrazole. Chromium trioxide complex steroidal .DELTA.5-7-ketones. The Journal of Organic Chemistry. 43(10). 2057–2059. 255 indexed citations
9.
Salmond, William G., et al.. (1978). ChemInform Abstract: A STEREOSELECTIVE WITTIG REAGENT AND ITS APPLICATION TO THE SYNTHESIS OF 25‐HYDROXYLATED VITAMIN D METABOLITES. Chemischer Informationsdienst. 9(27). 2 indexed citations
10.
Salmond, William G., et al.. (1978). A stereoselective Wittig reagent and its application to the synthesis of 25-hydroxylated vitamin D metabolites. The Journal of Organic Chemistry. 43(4). 790–792. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026